Literature DB >> 509400

Acute hepatic vein thrombosis occurring during therapy for Hodgkin's disease: a case report.

A N Houghton, N Shafi, F R Rickles.   

Abstract

A case of fatal acute hepatic vein thrombosis occurred during treatment for Hodgkin's disease. At necropsy no evidence of Hodgkin's disease or obliterative venoocclusive disease of the liver was found. We speculate that Adriamycin, DTIC and/or vinblastine may have been responsible for this unusual disorder.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 509400     DOI： 10.1002/1097-0142(197912)44:6<2324::aid-cncr2820440648>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Dose adaptation of antineoplastic drugs in patients with liver disease.

Authors:  Lydia Tchambaz; Chantal Schlatter; Max Jakob; Anita Krähenbühl; Peter Wolf; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.

Authors:  D R Adkins; R Irvin; J Kuhn; D H Boldt; G D Roodman; D Salzman; C Freytes; D D Von Hoff; C F LeMaistre
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

3.  Hepatic vascular lesions associated with dacarbazine treatment.

Authors:  M A Greenstone; P M Dowd; D P Mikhailidis; P J Scheuer
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

4.  [Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].

Authors:  H Voigt; J Caselitz; M Jänner
Journal:  Klin Wochenschr       Date:  1981-03-02

Review 5.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.